Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia

Blood

Volumn 100, Issue 8, 2002, Pages 2703-2707

  Voso, Maria Teresa ^a,b   D'Alo', Francesco ^a,b   Putzulu, Rossana ^a,b   Mele, Luca ^a,b   Scardocci, Alessandra ^a,b   Chiusolo, Patrizia ^a,b   Latagliata, Roberto ^a,b   Lo Coco, Francesco ^a,b   Rutella, Sergio ^a,b   Pagano, Livio ^a,b   Hohaus, Stefan ^a,b   Leone, Giuseppe ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; GLUTATHIONE TRANSFERASE; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RESISTANCE; CANCER SURVIVAL; CONTROLLED STUDY; CYTOGENETICS; DNA DETERMINATION; DRUG FATALITY; DRUG RESPONSE; ENZYME ACTIVITY; FEMALE; GENE DELETION; GENE LOCUS; GENE MUTATION; GENOTYPE; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; HUMAN CELL; INCIDENCE; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; MULTIVARIATE ANALYSIS; NULL ALLELE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

EID: 0037108108     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V100.8.2703     Document Type: Article

References (27)

1. Salinas AE, Wong MG. Glutathione S-transferases-a review. Curr Med Chem. 1999;6:279-309.
2. Strange RC, Lear JT, Fryer AA, Glutathione S-transferase polymorphisms: influence on susceptibility to cancer. Chem Biol Interact. 1998;111-112:351-364.
3. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 1997;6: 733-743.
4. el-Zein R, Conforti-Froes N, Au WW. Interactions between genetic predisposition and environmental toxicants for development of lung cancer. Environ Mol Mutagen. 1997;30:196-204.
5. Chen H, Sandler DP, Taylor JA, et al. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet. 1996;347:295-297.
6. Chen C-L, Liu Q, Pui CH, et al. Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemia. Blood. 1997;89:1701-1707.
7. Krajinovic M, Labuda D, Richer C, Karimi S, Sinnett D. Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood. 1999;93:1496-1501.
8. Sinnett D, Krajinovic M, Labuda D. Genetic susceptibility to childhood acute ly'mphoblastic leuke. mia. Leuk Lymphoma. 2000;38:447-462.
9. Sasai Y, Horiike S, Misawa S, et al. Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia. Leuk Res. 1999; 23:975-981.
10. Rollinson S, Roddam P, Kane E, et al. Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia. Carcinogenesis. 2000;21:43-47.
11. Basu T, Gale R-E, Langabeer S, Linch DC. Glutathione S-transferase theta 1 (GSTT1) gene defect in myelodysplasia and acute myeloid leukaemia. Lancet. 1997;349:1450.
12. Atoyebi W, Kusec R, Fidler C, Peto TE, Boultwood J, Wainscoat JS. Glutathione S-transferase gene deletions in myelodysplasia. Lancet. 1997; 349:1450-1451.
13. Woo M H, Shuster JJ, Chen C, et al. Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid malignancies. Leukemia. 2000;14:232-237.
14. Crump C, Chen C, Appelbaum FR, et al. Glutathione S-transferase theta 1 gene deletion and risk of acute myeloid leukemia. Cancer Epidemiol Biomarkers Prev. 2000;9:457-460.
15. Preudhomme C, Nisse C, Hebbar M, et al. Glutathione S transferase theta 1 gene defects in myelodysplastic syndromes and their correlation with karyotype and exposure to potential carcinogens. Leukemia. 1997;11:1580-1582.
16. Cheson BD, Cassileth PA, Head DR, et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol. 1990;8: 813-819.
17. Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 Trial. Blood. 1998;92:2322-2333.
18. Allan JM, Wild CP, Rollinson S, et al. Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc Natl Acad Sci U S A. 2001;98: 11592-11597.
19. Stirewalt DL, Kopecky KJ, Meshinchi S, et al. FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia. Blood. 2001; 97:3589-3595.
20. Kottaridis PD, Gale RE, Frew ME, et al. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood. 2001;98:1752-1759.
21. Kearns PR, Pieters R, Rottier MM, Pearson AD, Hall AG. Raised blast glutathione levels are associated with an increased risk of relapse in childhood acute lymphocytic leukemia. Blood. 2001; 97:393-398.
22. Paydas S, Yuregir GT, Sahin B, Seyrek E, Burgut R. Intracellular glutathione content in leukemias. Oncology. 1995;52:112-115.
23. Stanulla M, Schrappe M, Brechlin AM, Zimmermann M, Welte K. Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study. Blood. 2000;95:1222-1228.
24. Davies SM, Robison LL, Buckley JD, et al. Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia. J Clin Oncol. 2001;19:1279-1287.
25. Howells RE, Redman CW, Dhar KK, et al. Association of glutathione S-transferase GSTM1 and GSTT1 null genotypes with clinical outcome in epithelial ovarian cancer. Clin Cancer Res. 1998; 4:2439-2445.
26. Smyth MJ. Glutathione modulates activation-dependent proliferation of human peripheral blood lymphocyte populations without regulating their activated function. J Immunol. 1991;146:1921-1927.
27. Macho A, Hirsch T, Marzo I, et al. Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis. J Immunol. 1997;158:4612-4619.